AC
BIO icon

Avestar Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Avestar Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-582
Closed -$201K – 462
2024
Q1 		$201K Buy
+582
New +$191K 0.02% 426
2023
Q4 		– Sell
-599
Closed -$215K – 402
2023
Q3 		$215K Buy
+599
New +$231K 0.03% 316
2018
Q3 		– Sell
-3
Closed – – 839
2018
Q2 		$0 Hold
3
– – ﹤0.01% 884
2018
Q1 		$0 Buy
+3
New +$764 ﹤0.01% 835

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $18.8B AUM 17.33% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return